Delivery Order 68HERC22D0010-68HERC24F0252

Award Date 4/10/24
Potential Completion Date 4/9/25
Potential Value $381K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Environmental Protection Agency (EPA) Office of Research and Development awarded a $261,044.05 firm-fixed-price delivery order contract to Integrated Laboratory Systems, LLC for mammalian oral exposure studies. This work is being conducted under a $7.8 million indefinite delivery contract that was set aside for small businesses. The studies support the EPA's Center for Computational Toxicology and Exposure in assessing potential health and environmental impacts of chemicals. Integrated...
This is a federal contract award from the Environmental Protection Agency's (EPA) Office of Research and Development to Integrated Laboratory Systems, LLC (ILS), a subsidiary of Inotiv, Inc. The contract, valued at $127,123.94, is for conducting a non-Good Laboratory Practice (GLP) acute oral tolerability study for each chemical. This is a delivery order contract, with a firm fixed price pricing type, and has no set-aside designation. The contract supports the EPA's Center for Computational...
Integrated Laboratory Systems, LLC was awarded a $223,046 firm fixed price delivery order against an unidentified contract vehicle to conduct mammalian oral exposure studies for the Environmental Protection Agency's (EPA) Office of Research and Development. The place of performance will be in Research Triangle Park, North Carolina and studies are required to be completed by June 13, 2023. No set aside designation was applied to this award to study the health impacts of chemicals, technologies or...
The Environmental Protection Agency Office of Research and Development awarded Integrated Laboratory Systems, LLC a $171,000 firm fixed price delivery order for mammalian oral exposure testing. The contract has no set-aside designation and work will be performed in Cincinnati, Ohio, with an expected completion date of October 14, 2022. As the EPA's research arm, the Office of Research and Development utilizes contractors to help assess the potential human health and environmental effects of...
The Environmental Protection Agency Office of Research and Development awarded a $238,223.06 firm fixed price delivery order to Integrated Laboratory Systems, LLC for mammalian oral exposure studies for two chemicals. Per the task order, Integrated Laboratory Systems will conduct two tolerability studies and two five-day repeat dose studies outlined in Attachment 1. The period of performance is through February 24, 2024 at the place of performance in Cincinnati, Ohio. Integrated Laboratory...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a small business contractor, in the amount of $167,767.00. The contract is for a "Fragrance Study Titled, 'Evaluation of the Allergenicity and Sensitization Potential of Fragrance Substances Based on Survey of Scientific Literature.'" As a small business set-aside contract, ILS will conduct this research study on the allergenicity and...
This firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a for-profit research and testing services company. The contract, valued at $88,156.00, is for a pilot study on the in vivo genetic toxicity of the chemical NNK (nicotine-derived nitrosamine ketone) in mice using the intraperitoneal route of administration. This contract is part of a larger $7.8 million indefinite delivery contract (IDC) awarded by...
The Environmental Protection Agency Office of Research and Development awarded a $20,600 firm fixed price delivery order contract to Integrated Laboratory Systems, LLC of Morrisville, North Carolina. The contract is for mammalian oral exposure studies for the Center for Computational Toxicology and Exposure. No set-aside designation was used for this award. The place of performance is Morrisville, North Carolina and the period of performance runs from May 3, 2022 through October 14, 2022. The...
This is a federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The contract, worth $796,082.35, was awarded to Integrated Laboratory Systems, LLC (ILS) on October 21, 2015 and is scheduled for completion on February 5, 2021. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and is not set aside for any specific business category. The purpose of the...
This federal contract award to Integrated Laboratory Systems, LLC (ILS), a subsidiary of Inotiv, Inc., is for genetic toxicity testing services in support of the National Toxicology Program (NTP) administered by the National Institute of Environmental Health Sciences (NIEHS). The $5,523,088.27 definitive contract, awarded on September 18, 2013, is a cost-plus-fixed-fee arrangement with a period of performance through June 13, 2023. ILS, a for-profit scientific research and testing company,...
  • 68HERC22D0010
    Indefinite Delivery Contract
  • 68HERC22D0010-68HERC24F0252
    Delivery Order

This is a firm fixed-price delivery order under the EPA's $7.8 million indefinite delivery contract (IDC) awarded to Integrated Laboratory Systems, LLC (ILS), a small business contractor. The delivery order, valued at $381,371.82, is for ILS to conduct mammalian oral exposure studies at EPA facilities to support the agency's Center for Computational Toxicology and Exposure. This work contributes data on chemical exposure pathways to inform the EPA's regulatory programs and mission to protect human health and the environment. ILS has received over $1.5 million in delivery orders to date under this IDC, which runs through January 2027. The company has also received an NIEHS grant of $99,572 to develop a new human cell-based approach for assessing chemical mutagenicity as an alternative to in vivo animal testing, aligning with the shift towards reducing animal studies in regulatory toxicology.

Generated 12/10/24, 2:19 PM